$BVAXF Clinical Trial Affirms CoviDTH Diagnostic Approach to screen for T cell-mediated immune response to SARS-CoV-2 is safe and effective in humans

on August 3, 2021 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
BVAXF
Company:
BioVaxys Technology Corp.
Source:
PR Newswire
Read more

$BVAXF BioVaxys Closes Final Tranche Of Non-Brokered Private Placement

on July 28, 2021 News and Tags: , , , with 0 comments
Time:
11:00 PM
Symbol:
BVAXF
Company:
BioVaxys Technology Corp.
Source:
PR Newswire
Read more

$ABT Covid-19 Tests Innovations Drawing New Interest from FDA and Consortiums

on July 22, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
12:45 PM
Symbol:
ABT
Source:
PR Newswire
Read more

$BNTX Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases

on July 22, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
9:30 AM
Symbol:
BNTX
Source:
PR Newswire
Read more

$BVAXF FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical Trials Of CoviDTH

on July 22, 2021 News and Tags: , , , with 0 comments
Time:
9:16 AM
Symbol:
BVAXF
Company:
BioVaxys Technology Corp.
Source:
PR Newswire
Read more

$BVAXF BioVaxys Announces Non-Brokered Private Placement

on June 28, 2021 News and Tags: , , , with 0 comments
Time:
10:05 PM
Symbol:
BVAXF
Company:
BioVaxys Technology Corp.
Source:
PR Newswire
Read more

$BVAXF Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing

on May 24, 2021 News and Tags: , , , , , with 0 comments
Time:
8:00 AM
Symbol:
BVAXF
Company:
BioVaxys Technology Corp.
Source:
PR Newswire
Read more

$BVAXF BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH® Diagnostic

on April 29, 2021 News and Tags: , , , , , with 0 comments
Time:
8:24 AM
Symbol:
BVAXF
Company:
BioVaxys Technology Corp.
Source:
PR Newswire
Read more